GT200100149A - Composicion de eletriptan en forma de particulas. - Google Patents
Composicion de eletriptan en forma de particulas.Info
- Publication number
- GT200100149A GT200100149A GT200100149A GT200100149A GT200100149A GT 200100149 A GT200100149 A GT 200100149A GT 200100149 A GT200100149 A GT 200100149A GT 200100149 A GT200100149 A GT 200100149A GT 200100149 A GT200100149 A GT 200100149A
- Authority
- GT
- Guatemala
- Prior art keywords
- composition
- eletriptan
- particles
- pharmaceutical composition
- trimethylamethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Luminescent Compositions (AREA)
Abstract
ESTA INVENCION PROPORCIONA UNA COMPOSICION FARMACEUTICA EN FORMA DE PARTICULAS, ADECUADAS PARA LA ADMINISTRACION POR VIA ORAL, QUE INCLUYE UN NUCLEO QUE CONTIENE ELETRIPTAN O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, ESTANDO REVESTIDO EL NUCLEO CON UN REVESTIMIENTO INSOLUBLE EN AGUA, Y PERMEABLE, QUE INCLUYE A UNO O MAS COPOLIMEROS ACRILICOS QUE CONTIENEN GRUPOS DE METACRILATO DE TRIMETILAMONIOETILO, Y SIENDO DICHA COMPOSICION CAPAZ DE CONSEGUIR UN CURSO SIGMOIDEO DE LIBERACION CONTROLADA DEL FARMACO. ESTA COMPOSICION FARMACEUTICA ES PARTICULARMENTE UTIL EN LA PREVENCION DE LA RECURRENCIA DE LA MIGRAÑA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0018968.8A GB0018968D0 (en) | 2000-08-02 | 2000-08-02 | Particulate composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200100149A true GT200100149A (es) | 2002-06-25 |
Family
ID=9896843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200100149A GT200100149A (es) | 2000-08-02 | 2001-07-25 | Composicion de eletriptan en forma de particulas. |
Country Status (38)
Country | Link |
---|---|
US (1) | US20020034545A1 (es) |
EP (1) | EP1365748B1 (es) |
JP (1) | JP2004505034A (es) |
KR (1) | KR20030024820A (es) |
CN (1) | CN1630511A (es) |
AP (1) | AP2001002233A0 (es) |
AR (1) | AR030099A1 (es) |
AT (1) | ATE308978T1 (es) |
AU (1) | AU2001270932A1 (es) |
BG (1) | BG107361A (es) |
BR (1) | BR0112839A (es) |
CA (1) | CA2417887C (es) |
CZ (1) | CZ2003241A3 (es) |
DE (1) | DE60114887T2 (es) |
EA (1) | EA200300110A1 (es) |
EC (1) | ECSP034451A (es) |
EE (1) | EE200300051A (es) |
ES (1) | ES2250429T3 (es) |
GB (1) | GB0018968D0 (es) |
GT (1) | GT200100149A (es) |
HR (1) | HRP20030036A2 (es) |
HU (1) | HUP0301453A2 (es) |
IL (1) | IL153494A0 (es) |
IS (1) | IS6649A (es) |
MA (1) | MA26934A1 (es) |
MX (1) | MXPA03000999A (es) |
NO (1) | NO20030498D0 (es) |
NZ (1) | NZ522976A (es) |
OA (1) | OA12348A (es) |
PA (1) | PA8523101A1 (es) |
PE (1) | PE20020385A1 (es) |
PL (1) | PL359847A1 (es) |
SK (1) | SK1082003A3 (es) |
SV (1) | SV2002000574A (es) |
TN (1) | TNSN01115A1 (es) |
UY (1) | UY26861A1 (es) |
WO (1) | WO2002009675A1 (es) |
ZA (1) | ZA200300868B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
US20060134012A1 (en) * | 2002-12-16 | 2006-06-22 | Symington John M | Temporary pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing |
JP2006522790A (ja) * | 2003-04-11 | 2006-10-05 | ファイザー・インク | エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
WO2005120456A2 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Formulation of eletriptan |
WO2006013431A1 (en) * | 2004-07-29 | 2006-02-09 | Pfizer Limited | Stable controlled-release pharmaceutical formulation of eletriptan |
KR20070115918A (ko) * | 2005-01-31 | 2007-12-06 | 교린 세이야꾸 가부시키 가이샤 | 멀티플 유닛형 경구 서방성 제제 및 그 제조방법 |
ES2434416T3 (es) | 2005-08-10 | 2013-12-16 | Add Advanced Drug Delivery Technologies, Ltd. | Preparación oral con liberación controlada |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
EP2359830B1 (en) | 2006-04-26 | 2012-09-19 | Supernus Pharmaceuticals, Inc. | Controlled released preparations of oxcarbazepine having sigmoidal release profile |
WO2008115797A1 (en) * | 2007-03-16 | 2008-09-25 | Pavo, Inc. | Therapeutic compositions and methods |
US8137661B2 (en) | 2007-07-25 | 2012-03-20 | Biolex Therapeutics, Inc. | Controlled release interferon drug products and treatment of HCV infections using same |
WO2011057676A1 (en) * | 2009-11-16 | 2011-05-19 | Evonik Röhm Gmbh | A process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent |
FR3025425A1 (fr) * | 2014-09-09 | 2016-03-11 | Charleston Lab Inc | Compositions pharmaceutiques |
GB201716716D0 (en) * | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624732B1 (fr) * | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US5411745A (en) * | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
GB9922963D0 (en) * | 1999-09-28 | 1999-12-01 | Pfizer Ltd | Polymorphic salt |
FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
-
2000
- 2000-08-02 GB GBGB0018968.8A patent/GB0018968D0/en not_active Ceased
-
2001
- 2001-07-18 OA OA1200300020A patent/OA12348A/en unknown
- 2001-07-18 PL PL35984701A patent/PL359847A1/xx not_active Application Discontinuation
- 2001-07-18 SK SK108-2003A patent/SK1082003A3/sk not_active Application Discontinuation
- 2001-07-18 CN CNA018134041A patent/CN1630511A/zh active Pending
- 2001-07-18 KR KR10-2003-7001402A patent/KR20030024820A/ko not_active Application Discontinuation
- 2001-07-18 JP JP2002515228A patent/JP2004505034A/ja active Pending
- 2001-07-18 EA EA200300110A patent/EA200300110A1/ru unknown
- 2001-07-18 AU AU2001270932A patent/AU2001270932A1/en not_active Abandoned
- 2001-07-18 AP APAP/P/2001/002233A patent/AP2001002233A0/en unknown
- 2001-07-18 CA CA002417887A patent/CA2417887C/en not_active Expired - Fee Related
- 2001-07-18 EE EEP200300051A patent/EE200300051A/xx unknown
- 2001-07-18 WO PCT/IB2001/001279 patent/WO2002009675A1/en active IP Right Grant
- 2001-07-18 HU HU0301453A patent/HUP0301453A2/hu unknown
- 2001-07-18 ES ES01949819T patent/ES2250429T3/es not_active Expired - Lifetime
- 2001-07-18 CZ CZ2003241A patent/CZ2003241A3/cs unknown
- 2001-07-18 NZ NZ522976A patent/NZ522976A/en unknown
- 2001-07-18 MX MXPA03000999A patent/MXPA03000999A/es active IP Right Grant
- 2001-07-18 DE DE60114887T patent/DE60114887T2/de not_active Expired - Lifetime
- 2001-07-18 AT AT01949819T patent/ATE308978T1/de not_active IP Right Cessation
- 2001-07-18 EP EP01949819A patent/EP1365748B1/en not_active Expired - Lifetime
- 2001-07-18 IL IL15349401A patent/IL153494A0/xx unknown
- 2001-07-18 BR BR0112839-6A patent/BR0112839A/pt not_active Application Discontinuation
- 2001-07-25 US US09/912,774 patent/US20020034545A1/en not_active Abandoned
- 2001-07-25 PA PA20018523101A patent/PA8523101A1/es unknown
- 2001-07-25 GT GT200100149A patent/GT200100149A/es unknown
- 2001-07-30 SV SV2001000574A patent/SV2002000574A/es not_active Application Discontinuation
- 2001-07-30 UY UY26861A patent/UY26861A1/es not_active Application Discontinuation
- 2001-08-01 TN TNTNSN01115A patent/TNSN01115A1/fr unknown
- 2001-08-01 PE PE2001000770A patent/PE20020385A1/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103668A patent/AR030099A1/es unknown
-
2002
- 2002-12-05 IS IS6649A patent/IS6649A/is unknown
- 2002-12-06 BG BG107361A patent/BG107361A/bg unknown
-
2003
- 2003-01-21 HR HR20030036A patent/HRP20030036A2/hr not_active Application Discontinuation
- 2003-01-23 MA MA27009A patent/MA26934A1/fr unknown
- 2003-01-24 EC EC2003004451A patent/ECSP034451A/es unknown
- 2003-01-31 ZA ZA200300868A patent/ZA200300868B/en unknown
- 2003-01-31 NO NO20030498A patent/NO20030498D0/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200100149A (es) | Composicion de eletriptan en forma de particulas. | |
GT200000222A (es) | Forma de dosificacion de farmacos accionada por un hidrogel. | |
ITMI951223A1 (it) | Forma farmaceutica solida ad uso orale | |
AR038371A1 (es) | Formulaciones de azitromicina granuladas por via seca | |
SV2002000586A (es) | Formula de dosificacion de la droga accionada por hidrogel ref. pc11095/700006/b | |
CO5160262A1 (es) | Formulaciones farmaceuticas de liberacion controlada | |
TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
UY26704A1 (es) | Nueva composición farmacéutica | |
EP1366759A4 (en) | RAPID DELIMINATION TABLETS IN THE MOUTH | |
ATE442145T1 (de) | Pharmazeutische zusammensetzung mit einem benzodiazepin-derivat und einem hemmer des rsv- fusionsproteins | |
ES2185816T3 (es) | Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico. | |
CR9842A (es) | Composiciones de celecoxib | |
BRPI0410653A (pt) | composto, composição farmacêutica, e, uso de um composto ou um sal, solvato, hidrato ou n-óxido farmaceuticamente aceitável do mesmo | |
PE20010053A1 (es) | Formulacion de amoxicilina y clavulanato de potasio | |
PA8562101A1 (es) | Metodos para granulacion humeda de azitromicina | |
GB0406282D0 (en) | Therapeutic compounds | |
SV2002000235A (es) | Composiciones farmaceuticas que comprenden valdecoxib | |
AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
BRPI0412458A (pt) | composições farmacêuticas oralmente dosadas compreendendo um agente de liberação na forma micronizada | |
YU6401A (sh) | Primena eletriptana za izradu leka za prevenciju učestanog javljanja migrene | |
GT200300017A (es) | Sistema de suministro osmotico | |
AR038858A1 (es) | Combinacion | |
EP1313504A4 (en) | METHODS AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS | |
CR6858A (es) | Composiciones de eletriptan en forma de particulas que muestra el curso sigmoideo de liberacion controlada | |
AR022348A1 (es) | Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior |